Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18464
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPascoe, Claire-
dc.contributor.authorOw, Darren-
dc.contributor.authorPerera, Marlon-
dc.contributor.authorWoo, Henry H-
dc.contributor.authorJack, Gregory S-
dc.contributor.authorLawrentschuk, Nathan-
dc.date.accessioned2018-08-30T06:04:45Z-
dc.date.available2018-08-30T06:04:45Z-
dc.date.issued2017-07-
dc.identifier.citationTranslational andrology and urology 2017; 6(Suppl 2): S133-S141-
dc.identifier.issn2223-4691-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/18464-
dc.description.abstractBenign prostatic hyperplasia (BPH) is a common pathology causing lower urinary tract symptoms (LUTS) and may significantly impact quality of life. While transurethral resection of the prostate (TURP) remains the gold standard treatment, there are many evolving technologies that are gaining popularity. Photoselective vaporization of the prostate (PVP) is one such therapy which has been shown to be non-inferior to TURP. We aimed to review the literature and discuss factors to optimise patient outcomes in the setting of PVP for BPH. A comprehensive search of the electronic databases, including MEDLINE, Embase, Web of Science and The Cochrane Library was performed on articles published after the year 2000. After exclusion, a total of 38 papers were included for review. The evolution of higher powered device has enabled men with larger prostates and those on oral anticoagulation to undergo safely and successfully PVP. Despite continued oral anticoagulation in patients undergoing PVP, the risk of bleeding may be minimised with 5-Alpha Reductase Inhibitor (5-ARI) therapy however further studies are required. Pre-treatment with 5-ARI's does not hinder the procedure however more studies are required to demonstrate a reliable benefit. Current data suggests that success and complication rate is largely influenced by the experience of the operator. Post-operative erectile dysfunction is reported in patients with previously normal function following PVP, however those with a degree of erectile dysfunction pre-operatively may see improvement with alleviation of LUTS.-
dc.language.isoeng-
dc.subjectBenign prostatic hyperplasia (BPH)-
dc.subjectoutcomes-
dc.subjectphotoselective vaporization of the prostate (PVP)-
dc.subjectprostate-
dc.subjectsexual function-
dc.subjecturinary function-
dc.titleOptimising patient outcomes with photoselective vaporization of the prostate (PVP): a review.-
dc.typeJournal Article-
dc.identifier.journaltitleTranslational andrology and urology-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationSydney Adventist Hospital Clinical School, University of Sydney, Sydney, Australiaen
dc.identifier.affiliationYoung Urology Researchers Organisation (YURO), Melbourne, Australiaen
dc.identifier.doi10.21037/tau.2017.05.14-
dc.identifier.orcid0000-0001-8553-5618-
dc.identifier.orcid0000-0002-1138-6389-
dc.identifier.pubmedid28791232-
dc.type.austinJournal Article-
dc.type.austinReview-
Appears in Collections:Journal articles
Show simple item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.